On-Demand Webcast

Share

Program Content

Activities

  • PARPi in OC: Latest Evidence
    Key Questions on PARP Inhibitors in Ovarian Cancer: Experts Evaluate the Latest Evidence
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 20, 2021

    Expires: July 19, 2022

Faculty

cover img faculity

Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci

Professor of Medical Oncology
CRUK and UCL Cancer Trials Centre
UCL Cancer Institute
Honorary Consultant in Medical Oncology
Cancer Services
UCL Hospitals
London, United Kingdom

cover img faculity

Frederik Marmé, MD, PhD

Assistant Professor of Gynecology
Division of Gynecologic Oncology
Medical Faculty of Heidelberg
University of Heidelberg
Heidelberg, Germany

cover img faculity

Prof Isabelle Ray-Coquard, MD, PhD

President of the Gineco Group
Centre Leon Bérard
Laboratoire RESHAPE u1290
Université Claude Bernard Lyon Est
Lyon, France

Provided by

ProCE Banner

Supporters

AstraZeneca